| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |